Maltese Patient Received World's First ND1-LHON Gene Therapy Injection Donated by Neurophth in China

Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON

1st LHON INTERNATIONAL FORUM

41st Annual J.P. Morgan Healthcare Conference 2023 is approaching

Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON

Special interview with Dr. Satoshi Kashii on World Sight Day

Neurophth announces first patient dosed in Phase III clinical trial for the gene therapy treatment of LHON

Special interview with Dr. Patrick Yu-Wai-Man on International LHON Awareness Day

Neurophth Ranked as One of the MIT 50 Smartest Companies 2021